Home
DXCM
DXCM News

Latest DexCom Inc. (DXCM) News on April 2, 2025

DexCom (DXCM) Slid on Poor Execution and GLP-1 Drug Disruption Concerns

Insider Monkey

20 hours ago

DexCom (DXCM) Slid on Poor Execution and GLP-1 Drug Disruption Concerns

Government of Saskatchewan Expands Public Coverage for Dexcom Continuous Glucose Monitoring Systems

Business Wire

21 hours ago

Government of Saskatchewan Expands Public Coverage for Dexcom Continuous Glucose Monitoring Systems

DXCM Inks Deal With Nanowear to Boost CGM Application Beyond Diabetes

Zacks

2 days ago

DXCM Inks Deal With Nanowear to Boost CGM Application Beyond Diabetes

Dexcom rejects claims of unauthorized device changes in FDA warning letter

MedTech Dive

6 days ago

Dexcom rejects claims of unauthorized device changes in FDA warning letter

DXCM Stock Falls as FDA Warnings Raise Concern for 15-Day G7 Approval

Zacks

6 days ago

DXCM Stock Falls as FDA Warnings Raise Concern for 15-Day G7 Approval

DexCom (NasdaqGS:DXCM) Expands Wearable Integration and Appoints New Chief Commercial Officer

Simply Wall St.

7 days ago

DexCom (NasdaqGS:DXCM) Expands Wearable Integration and Appoints New Chief Commercial Officer

Dexcom’s FDA warning letter reveals unauthorized changes to sensors

MedTech Dive

7 days ago

Dexcom’s FDA warning letter reveals unauthorized changes to sensors

DXCM Stock Gains Following New Data on Upcoming G7 CGM Sensor

Zacks

7 days ago

DXCM Stock Gains Following New Data on Upcoming G7 CGM Sensor

Argus Research

7 days ago

DXCM: Raising target price to $77.00

Argus Research

7 days ago

DXCM: Raising target price to $40.00

MT Newswires

8 days ago

DexCom Names Jon Coleman as Chief Commercial Officer

Dexcom Appoints Jon Coleman as Chief Commercial Officer

Business Wire

8 days ago

Dexcom Appoints Jon Coleman as Chief Commercial Officer

Dexcom COO on 15-day glucose sensor, Type 2 coverage

MedTech Dive

8 days ago

Dexcom COO on 15-day glucose sensor, Type 2 coverage

DexCom (DXCM): 3 Reasons We Love This Stock

StockStory

9 days ago

DexCom (DXCM): 3 Reasons We Love This Stock

Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers

StockStory

12 days ago

Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers

3 Stocks That May Be Trading Below Estimated Value In March 2025

Simply Wall St.

13 days ago

3 Stocks That May Be Trading Below Estimated Value In March 2025

Nasdaq Sell-Off: 2 Brilliant Stocks to Buy No Matter What the Market Does Next

Motley Fool

14 days ago

Nasdaq Sell-Off: 2 Brilliant Stocks to Buy No Matter What the Market Does Next

Dexcom Report Unveiled at ATTD 2025 Reveals HCPs Favour Tech Over Medication for Future of Type 2 Care

Business Wire

14 days ago

Dexcom Report Unveiled at ATTD 2025 Reveals HCPs Favour Tech Over Medication for Future of Type 2 Care

DexCom, Inc. (DXCM): Among the Best Diabetes Stocks to Buy According to Billionaires

Insider Monkey

15 days ago

DexCom, Inc. (DXCM): Among the Best Diabetes Stocks to Buy According to Billionaires

Argus Research

16 days ago

Daily – Vickers Top Buyers & Sellers for 03/17/2025

DexCom CGM Sensor Sales to Continue Despite FDA Warning Letter

Zacks

19 days ago

DexCom CGM Sensor Sales to Continue Despite FDA Warning Letter

Analysts say Dexcom’s FDA warning unlikely to impact 2025 revenue

Medical Device Network

22 days ago

Analysts say Dexcom’s FDA warning unlikely to impact 2025 revenue

Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD)

StockStory

22 days ago

Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD)

Morningstar Research

22 days ago

Analyst Report: DexCom, Inc.

Why Dexcom Is On A Six-Day Losing Spree — But This Analyst Isn't Worried

Investor's Business Daily

23 days ago

Why Dexcom Is On A Six-Day Losing Spree — But This Analyst Isn't Worried

Top Stock Movers Now: Tesla, DexCom, Strategy, and More

Investopedia

23 days ago

Top Stock Movers Now: Tesla, DexCom, Strategy, and More

DexCom Stock Drops as Diabetes Devices Maker Gets FDA Warning Letter

Investopedia

23 days ago

DexCom Stock Drops as Diabetes Devices Maker Gets FDA Warning Letter

Dexcom Appoints Renée Galá to Board of Directors

Business Wire

23 days ago

Dexcom Appoints Renée Galá to Board of Directors

Dexcom receives warning letter based on FDA inspections of 2 plants

MedTech Dive

23 days ago

Dexcom receives warning letter based on FDA inspections of 2 plants

DexCom (NasdaqGS:DXCM) Shares Dip 1% Despite 7% Sales Growth

Simply Wall St.

23 days ago

DexCom (NasdaqGS:DXCM) Shares Dip 1% Despite 7% Sales Growth

Is DexCom, Inc. (DXCM) the Best Growth Stock Under $100 to Buy Now?

Insider Monkey

25 days ago

Is DexCom, Inc. (DXCM) the Best Growth Stock Under $100 to Buy Now?

Insiders Could Have Profited By Holding onto DexCom Shares Despite 12% Drop

Simply Wall St.

25 days ago

Insiders Could Have Profited By Holding onto DexCom Shares Despite 12% Drop

Dexcom receives FDA warning letter for two U.S. manufacturing facilities

Reuters

25 days ago

Dexcom receives FDA warning letter for two U.S. manufacturing facilities

DexCom Gets FDA Warning Letter After Inspections of Facilities

The Wall Street Journal

25 days ago

DexCom Gets FDA Warning Letter After Inspections of Facilities

MT Newswires

25 days ago

DexCom Receives US FDA Warning After Inspections

Argus Research

a month ago

DXCM: Rating decreased to a SELL

Argus Research

a month ago

DXCM: Raising target price to $29.00

Is DexCom, Inc.'s (NASDAQ:DXCM) ROE Of 27% Impressive?

Simply Wall St.

a month ago

Is DexCom, Inc.'s (NASDAQ:DXCM) ROE Of 27% Impressive?

MT Newswires

a month ago

Jefferies Adjusts Price Target on DexCom to $105 From $100, Keeps Buy Rating

MT Newswires

a month ago

Citigroup Adjusts Price Target on DexCom to $104 From $101, Maintains Buy Rating

3 Growth Stocks to Buy and Hold Forever

Motley Fool

a month ago

3 Growth Stocks to Buy and Hold Forever

Dexcom Announces Upcoming Conference Presentation

Business Wire

a month ago

Dexcom Announces Upcoming Conference Presentation

Investors Will Want DexCom's (NASDAQ:DXCM) Growth In ROCE To Persist

Simply Wall St.

a month ago

Investors Will Want DexCom's (NASDAQ:DXCM) Growth In ROCE To Persist

Reflecting On Patient Monitoring Stocks’ Q4 Earnings: DexCom (NASDAQ:DXCM)

StockStory

a month ago

Reflecting On Patient Monitoring Stocks’ Q4 Earnings: DexCom (NASDAQ:DXCM)

Got $200? 2 Healthcare Stocks to Buy and Hold Forever

Motley Fool

a month ago

Got $200? 2 Healthcare Stocks to Buy and Hold Forever

Argus Research

a month ago

DXCM: Lowering target price to $27.00

Argus Research

a month ago

DXCM: Lowering target price to $93.00

Seasoned Biopharmaceutical Industry Executives Teri Lawver and Jerry Durso Appointed to Altimmune Board of Directors

GlobeNewswire

a month ago

Seasoned Biopharmaceutical Industry Executives Teri Lawver and Jerry Durso Appointed to Altimmune Board of Directors

The Zacks Analyst Blog Highlights AbbVie, Amgen, Stryker, Dexcom and Medtronic

Zacks

a month ago

The Zacks Analyst Blog Highlights AbbVie, Amgen, Stryker, Dexcom and Medtronic

4 Seniors & Aging Demographics Stocks to Watch Right Now

Zacks

a month ago

4 Seniors & Aging Demographics Stocks to Watch Right Now

3 Stocks On US Exchange Estimated To Be Undervalued By Up To 36.2%

Simply Wall St.

a month ago

3 Stocks On US Exchange Estimated To Be Undervalued By Up To 36.2%

Argus Research

a month ago

DXCM: Raising target price to $95.00

Argus Research

a month ago

DXCM: Raising target price to $39.00

Is DexCom, Inc. (DXCM) the Best IoT Stock to Buy According to Analysts?

Insider Monkey

a month ago

Is DexCom, Inc. (DXCM) the Best IoT Stock to Buy According to Analysts?

Earnings Miss: DexCom, Inc. Missed EPS By 7.8% And Analysts Are Revising Their Forecasts

Simply Wall St.

2 months ago

Earnings Miss: DexCom, Inc. Missed EPS By 7.8% And Analysts Are Revising Their Forecasts

Analyst Cautiously Optimistic On DexCom As Competitive Pressures Loom

Benzinga

2 months ago

Analyst Cautiously Optimistic On DexCom As Competitive Pressures Loom

MT Newswires

2 months ago

DexCom Likely to Sustain Stability in 2025, Morgan Stanley Says

Dexcom Stock Makes A Recovery After Its Fourth-Quarter Fumble

Investor's Business Daily

2 months ago

Dexcom Stock Makes A Recovery After Its Fourth-Quarter Fumble

MT Newswires

2 months ago

Leerink Adjusts Price Target on DexCom to $95 From $86

MT Newswires

2 months ago

Barclays Adjusts Price Target on DexCom to $90 From $92

MT Newswires

2 months ago

Wells Fargo Adjusts Price Target on DexCom to $98 From $94

MT Newswires

2 months ago

Piper Sandler Adjusts Price Target on DexCom to $100 From $90

MT Newswires

2 months ago

Citigroup Adjusts Price Target on DexCom to $101 From $91

MT Newswires

2 months ago

Canaccord Genuity Adjusts Price Target on DexCom to $103 From $99

MT Newswires

2 months ago

Bernstein Adjusts Price Target on DexCom to $100 From $89

Is DexCom, Inc. (DXCM) the Best Medical Device Stock to Buy?

Insider Monkey

2 months ago

Is DexCom, Inc. (DXCM) the Best Medical Device Stock to Buy?

DexCom (DXCM) To Report Earnings Tomorrow: Here Is What To Expect

StockStory

2 months ago

DexCom (DXCM) To Report Earnings Tomorrow: Here Is What To Expect

Is It Time To Consider Buying DexCom, Inc. (NASDAQ:DXCM)?

Simply Wall St.

2 months ago

Is It Time To Consider Buying DexCom, Inc. (NASDAQ:DXCM)?

DXCM Q4 Earnings to Reflect Market Expansion & Stelo Impact?

Zacks

2 months ago

DXCM Q4 Earnings to Reflect Market Expansion & Stelo Impact?

Countdown to DexCom (DXCM) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS

Zacks

2 months ago

Countdown to DexCom (DXCM) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS

An Intrinsic Calculation For DexCom, Inc. (NASDAQ:DXCM) Suggests It's 29% Undervalued

Simply Wall St.

2 months ago

An Intrinsic Calculation For DexCom, Inc. (NASDAQ:DXCM) Suggests It's 29% Undervalued

DexCom (DXCM) Q4 Earnings Preview: What's in the Cards?

Zacks

2 months ago

DexCom (DXCM) Q4 Earnings Preview: What's in the Cards?

Should You Buy DexCom Stock Before Feb. 13?

Motley Fool

2 months ago

Should You Buy DexCom Stock Before Feb. 13?

Argus Research

2 months ago

DXCM: Rating increased to a HOLD

Argus Research

2 months ago

DXCM: Rating decreased to a SELL

Here’s Why Aristotle Atlantic Focus Growth Strategy Sold its Stake in DexCom (DXCM)

Insider Monkey

2 months ago

Here’s Why Aristotle Atlantic Focus Growth Strategy Sold its Stake in DexCom (DXCM)

Possible Bearish Signals With DexCom Insiders Disposing Stock

Simply Wall St.

2 months ago

Possible Bearish Signals With DexCom Insiders Disposing Stock

MT Newswires

2 months ago

DexCom Shares Rise Following Upgrade From Redburn Atlantic

Prediction: This Top Growth Stock Will Outperform the Market in the Next Decade

Motley Fool

2 months ago

Prediction: This Top Growth Stock Will Outperform the Market in the Next Decade

Got $2,000? 2 Top Growth Stocks to Buy and Hold for Years

Motley Fool

2 months ago

Got $2,000? 2 Top Growth Stocks to Buy and Hold for Years

MT Newswires

2 months ago

Redburn Atlantic Upgrades DexCom to Buy From Neutral, Adjusts Price Target to $115 From $85

Argus Research

2 months ago

Daily – Vickers Top Buyers & Sellers for 01/31/2025

MT Newswires

2 months ago

Dexcom Insider Sold Shares Worth $2,899,367, According to a Recent SEC Filing

Dexcom Schedules Fourth Quarter and Fiscal Year 2024 Earnings Release and Conference Call for February 13, 2025 at 4:30 p.m. Eastern Time.

Business Wire

2 months ago

Dexcom Schedules Fourth Quarter and Fiscal Year 2024 Earnings Release and Conference Call for February 13, 2025 at 4:30 p.m. Eastern Time.

Argus Research

2 months ago

DXCM: Raising target price to $51.00

Argus Research

2 months ago

DXCM: Raising target price to $71.00

Should We Be Delighted With DexCom, Inc.'s (NASDAQ:DXCM) ROE Of 34%?

Simply Wall St.

2 months ago

Should We Be Delighted With DexCom, Inc.'s (NASDAQ:DXCM) ROE Of 34%?

ClearPoint Neuro (CLPT) Surges 22.5%: Is This an Indication of Further Gains?

Zacks

2 months ago

ClearPoint Neuro (CLPT) Surges 22.5%: Is This an Indication of Further Gains?

Argus Research

2 months ago

TRUP: Raising target price to $50.00

Argus Research

2 months ago

DXCM: Raising target price to $69.00

DXCM's Preliminary Results Show Strong Growth: How to Play the Stock?

Zacks

2 months ago

DXCM's Preliminary Results Show Strong Growth: How to Play the Stock?

3 US Stocks Estimated To Be Trading Below Their Intrinsic Value In January 2025

Simply Wall St.

2 months ago

3 US Stocks Estimated To Be Trading Below Their Intrinsic Value In January 2025

MT Newswires

2 months ago

Barclays Adjusts DexCom Price Target to $92 From $113, Maintains Equal Weight Rating

How Dexcom and ŌURA are unifying two distinct market sectors

Medical Device Network

2 months ago

How Dexcom and ŌURA are unifying two distinct market sectors

DexCom (NASDAQ:DXCM) shareholder returns have been decent, earning 44% in 5 years

Simply Wall St.

2 months ago

DexCom (NASDAQ:DXCM) shareholder returns have been decent, earning 44% in 5 years

Morningstar Research

3 months ago

Analyst Report: DexCom, Inc.

Why DexCom, Inc. (DXCM) Is Skyrocketing

Insider Monkey

3 months ago

Why DexCom, Inc. (DXCM) Is Skyrocketing

S&P 500 Gains and Losses Today: UnitedHealth Stock Ails as Results Fall Short

Investopedia

3 months ago

S&P 500 Gains and Losses Today: UnitedHealth Stock Ails as Results Fall Short

Investing.com

3 months ago

Baird raises DexCom stock to outperform, target to $104

MT Newswires

3 months ago

Baird Upgrades DexCom to Outperform From Neutral, Adjusts Price Target to $104 From $86

Share on Social Networks: